We have identified a target antigen in autoimmune cerebellar degeneration, p-NAP, that is closely related to the J~-adaptin and I~-COP coat proteins. J~-NAP is a nonclathrin-associated phosphoprotein expressed exclusively in neurons, from E12 through adulthood, p-NAP is present in the neuronal soma and nerve terminal as soluble and membrane-bound pools and is associated with a discrete set of nerve-terminal vesicles. These results establish I~-NAP as a neuron-specific vesicle coat protein. We propose a model in which p-NAP mediates vesicle transport between the soma and the axon terminus and suggest that J~-NAP may represent a general class of coat proteins that mediates apical transport in polarized cells.
Introduction
A unique approach to the identification of neuron-specific proteins is through the analysis of human autoimmune neurologic degenerations (AINDs). The best characterized of these are paraneoplastic disorders (Posner and Furneaux, 1990; Darnell, 1994) , in which ectopic expression of neuron-specific proteins in tumors leads to an effective anti-tumor immune response and, secondarily, to autoimmune degeneration of neurons expressing these proteins. It is believed that a requirement for the immune reaction to these antigens in tumor cells is that they are normally sequestered from the immune system as neuronspecific proteins. Although the mechanism of neuronal degeneration is unclear, high titer antibodies present in the serum and cerebrospinal fluid (CSF) recognize discrete antigens by Western blot and immunohistochemical analyses. Thus, the identification and characterization of such antigens provides a means of understanding AIND and identifying neuron-specific proteins that are likely to play critical roles in the function and viability of neurons.
A distinct subset of AIND target antigens localize to the nerve terminal. Several, including synapt0tagmin (MartinMoutot et al., 1993) , amphiphysin Folli et al., 1993) , and glutamic acid decarboxylase (Solimena et al., 1988; Christgau et al., 1992; Darnell et al., 1993; Solimena and DeCamilli, 1993) , are associated with nerve-terminal vesicles. This suggests that nerve-terminal proteins, particularly vesicle-associated proteins, may be especially immunogenic or susceptible (or both) to autoimmune attack, although no mechanism for such a sensitivity is known. Antibodies against glutamic acid decarboxylase (the enzyme that produces the neurotransmitter y-aminobutyric acid [GABA] ) present in the CSF of patients with stiff-man syndrome may interfere with enzyme function, since GABA agonists reverse the neurologic disease symptoms (Howard, 1963) . Thus, AIND antisera may be of particular value in identifying and characterizing functionally important proteins associated with nerve-terminal vesicles.
Many proteins associated with intracellular vesicles in neurons are factors common to all cells (Rothman, 1994) , and thus less likely to be candidate AIND antigens. A number of vesicle-associated proteins, however, have been carefully documented to be neuron specific, including some synaptic vesicle proteins (DeBello et al., 1993; Greengard et al., 1993; Bajjalieh et al., 1994) , t-SNARES (Bennett et al., 1992) , SNAP proteins (Whiteheart et al., 1993) , and the autoantigens synaptotagmin (Hilbush and Morgan, 1994) and amphiphysin (Lichte et al., 1992 ). An important subset of vesicle-associated proteins that regulate intracellular vesicle traffic are the coat proteins, multisubunit complexes that include both general and neuronspecific variants. AP-1 or AP-2 coat protein adaptors associate with clathrin in all cells to mediate vesicle transport from the plasma membrane (AP-2) or the lTans-GoIgi network (AP-1) to endosomes (Pearse and Robinson, 1990) ; these coatomers consist of large adaptin proteins (m 6, 13', or y) noncovalently linked to smaller subunits (AP50 and AP17; Pearse and Robinson, 1990; Robinson, 1994) . Nonclathrin-associated coat protein complexes, COPI (Malhotra et al., 1989) and COPII (Barlowe et al., 1994) , mediate vesicle traffic within the endoplasmic reticulum-Golgi apparatus. One subunit of COPI, I3-COP, shows significant homology to ~-adaptin (Duden et al., 1991 ; Serafini et al., 1991) , suggesting functional similarity between these protein families.
Neuron-specific variants of clathrin (Stamm et al., 1992) , ~-adaptin (Pley and Parham, 1993) , and AP50 (Pevsner et al., 1994) have been described. Such variants may be related to the role of clathrin-coated vesicles (CCVs) in the nerve terminal, where they are involved in the reuptake of synaptic vesicles (Maycox et al., 1992) , perhaps in part through an interaction between AP-2 and synaptotagmin (Zhang et al., 1994) . The recycling vesicles are thought to reform by budding from an axonal endosome (Heuser and Reese, 1973) , and this has been suggested to involve additional neuronal coat proteins (Matter and Mellman, 1994; Mundigl and DeCamilli, 1994) , although such proteins have not been identified. Neuron-specific coat proteins may also play a role in the sorting and transport of membrane proteins between the neuronal cell body and the axon terminus. For example, KIF1A and KIF2, kinesin motor proteins, mediate anterograde axonal transport of vesicles that contain different sets of nerve-terminal membrane proteins (Noda et al., 1995; Okada et al., 1995) , suggesting that these proteins are sorted into different classes of vesicles in the cell body. We have characterized an anti-neuronal antibody present in the serum and CSF of a patient with cerebellar degeneration that recognizes a neuronal protein distinct from target antigens previously described in cerebellar AIND (Darnell et al., 1991) . Using this antiserum, we now report the cloning and characterization of the gene encoding the target antigen. The encoded protein is a unique nonclathrin-associated coat protein homologous to I~-adaptin and 13-COP, and its expression is neuron specific from early in development through adulthood. We have named this protein 13-NAP, for neuronal adaptin-like protein. I3-NAP exists as cytoplasmic and membrane-bound pools in the nerve terminal and cell body and is associated with nerveterminal vesicles. These findings suggest a model in which I~-NAP plays an essential role in neuronal function as part of a coat protein complex that regulates vesicle traffic between the cell body and the axon terminus, and they raise the possibility that interference with the activity of this protein results in cerebellar degeneration.
Results
The I~-NAP Gene Encodes a Cerebellar Degeneration Target Antigen Antiserum (Nb) from a patient with cerebellar degeneration (Darnell et al., 1991) Figure  1A) . A translational initiation codon surrounded by a weak Kozak consensus sequence is present at bp 68, and a stop codon is present at bp 3359. Although no upstream stop codon was found, comparison of 500 bp of mouse and human cDNAs immediately downstream of the ATG at bp 68 reveals that they are highly conserved (90% nucleic acid identity and 100% amino acid identity; data not shown), while the sequences immediately upstream of this ATG are not conserved (36% nucleic acid identity and 8% amino acid identity)..-Fhese observations suggest that the 3.4 kb composite cDNA sequence encompasses the fulllength coding sequence for this gene. Analysis of the predicted amino acid sequence revealed significant homology in the N-terminal 577 amino acids to the coat proteins l~-adaptin and, to a lesser degree, B-COP (Figures 1A and 1B) . The N-terminus of 13-NAP shares sequence similarity with ~-adaptins of all species and has weak homology to y-adaptin (data not shown); the greatest similarity is to the Drosophila and human 13-adaptins, to which it is 36% identical (50% similarity) in two regions (between amino acids 41-577), which are interrupted by a unique 100 amino acid domain ( Figure 1B ). This degree of sequence similarity is greater than that found between 13-adaptin and I~-COP, which are -17% identical over the N-terminal 450 amino acids (Duden et al., 1991) . Within this conserved region, ~-NAP contains a 7 amino acid consensus sequence (Wl (L/I) GEY) found in all adaptins (a, ]3, and y) and ~-COP ( Figure 1A ; Duden et al., 1991) . The predicted B-NAP protein harbors no signal sequence or transmembrane domain and has many potential phosphorylation sites. Taken together, these data indicate that the i~-NAP gene encodes a protein highly conserved throughout evolution that is likely to mediate some aspect of vesicle trafficking.
The homology between B-NAP and the ~-adaptin and B-COP proteins ends abruptly in the C-terminus of I~-NAP (distal to amino acid 577; Figures 1A and 1 B) . Variability in the C-terminal region of adaptin family members (c~, 13, and y) and J3-COP has been noted; while poorly understood, these domains may mediate specific protein-protein interactions (Kirchhausen et al., 1989; Robinson, 1994) . kNbl begins within this C-terminal domain, at amino acid 647 of the full-length protein. Notably, the first 142 (N-terminal) amino acids of kNbl are highly charged and have a high hydrophilicity and antigenicity profile (Figure 1B) . To test whether this 150 amino acid peptide fragment encoded the epitope reactive with Nb antiserum, we subcloned and expressed it as a glutathione S-transferase fusion protein (GST-Nb). The GST-Nb fusion protein was reactive with Nb antiserum at serum dilutions of up to 1: 16,000 ( Figure 1C ) and with Nb CSF at dilutions of up to 1:500 (data not shown). No reactivity was seen with unrelated paraneoplastic sera or antisera from more than 50 patients with small-cell lung cancer without neurologic disease at dilutions of 1:50. To define further the relationship between the kNbl clone and the neuronal antigen detected by Nb antiserum, we used the GST-Nb fusion protein to generate rabbit Nb antibodies and to affinity purify human and rabbit Nb antiserum. Affinity-purified rabbit Nb antiserum reacted with a mouse brain protein of the same molecular mass as the antigen recognized by native human Nb antiserum ( Figure 1D ).
The affinity-purified human and rabbit Nb antisera were also used for immunohistochemical analysis of adult mouse brains. Immunohistochemistry revealed high levels of B-NAP expression in the cytoplasm and processes of neurons throughout the central and peripheral nervous system, including but not limited to Purkinje, hippocampal, and cortical neurons (Figures 2A-2C ; data not shown); this pattern of reactivity was identical to that seen with native Nb antiserum. In more darkly stained sections, I3-NAP reactivity could be detected in the molecular layer, but no reactivity was evident in glial cells or cells outside of the nervous system (Darnell et al., 1991 ; data not shown) . These data support the conclusion that the kNbl clone encodes the antigen recognized by Nb autoimmune antisera.
Cellular and Developmental Expression of B-NAP
Immunofluorescence was performed to examine further the cellular localization of I~-NAP. Confocal laser images Figure 2 . Detection of IB-NAP Expression by Immunohistochemistry (A-C) Frozen sections of adult mouse brain were labeled with human or rabbit affinitypurified Nb antibody, and labeling was detected by horseradish peroxidase-coupled secondary antibody. Immunoreactivity is evident within the Purkinje neurons of the cerebellum (A) and throughout the hippocampus (13). At higher magnification, reactivity is evident within the neuronal cell body and processes of Purkinje neurons (C). !mmunoreactivity was blocked by an excess of GST-Nb fusion protein (data not shown), and normal human serum and preimmune rabbit serum showed no reactivity. (D and E) Confocal laser microscopy of mouse cerebellum, revealing diffuse reacti~'ity in Purkinje cell cytoplasm (P) and weaker reactivity in the molecular (M) and granular (G) layers; this contrasts with the punctate cellular staining in Purkinje cells seen with the lysosomal membrane marker LAMP (E). of mouse cerebellum revealed that a significant fraction of the neuronal cell body staining of 13-NAP was cytoplasmic, in contrast with the punctate staining of a lysosomal membrane marker LAMP ( Figures 2D and 2E ). Weak 13-NAP im munoreactivity was also evident within the granular layer of the cerebellum ( Figure 2D ) in a pattern reminiscent of that seen with proteins localized to the axon terminus (McPherson et al., 1994) . To analyze the tissue specificity of 15-NAP m RNA expression, we performed Northern blot and in situ hybridization analyses using a I~-NAP riboprobe. On Northern blot analysis, a highly brain-specific transcript of 4.2 kb was detected; of seven other tissues probed, none expresses this RNA ( Figure 3A) . In situ hybridization confirmed and extended this observation; 13-NAP mRNA was specifically expressed in the nervous system of the developing mouse at all embryonic stages examined (embryonic day 12 [E12], E14, E15, E17, postnatal day 0 [P0], and P8; Figure  3B ; data not shown). R-NAP m RNA was expressed in postmitotic neurons throughout the central and peripheral nervous system; 13-NAP mRNA is absent from both the mitotic neuroepithelium of the developing neocortex ( Figure 3C ) and the mitotic external granular layer of the developing cerebellum ( Figures 3D and 3E ). In the adult mouse brain, fJ-NAP mRNA remained neuron specific and was detectable in all neurons, with highest levels in cerebellar Purkinje ( Figure 3F ) and hippocampal neurons ( Figure 3G ).
Biochemical Characterization of B-NAP
The adaptor coat protein complexes AP-1 and AP-2 mediate vesicle transport in conjunction with clathrin coats (Robinson, 1994) , while the COP proteins have been found in association with nonclathrin-coated vesicles (Serafini et al., 1991; Rothman, 1994) . Within the brain, AP-2 has been demonstrated to associate with CCVs, including those involved in reuptake of synaptic vesicles in the nerve terminal (Maycox et al., 1992; Zhang, et al., 1994) . We investigated whether I~-NAP is associated with brain CCVs by analyzing Western blots of purified porcine brain CCVs. 15-NAP was not detected in CCV extracts, although we found (z-adaptin to be enriched in CCVs, as described previously ( Figure 4A ; Prasad and Keen, 1991) . Therefore, despite the high degree of homology between 13-NAP and 13-adaptin, B-NAP appears to be present in brain as a nonclathrin-associated protein.
Since I~-NAP contains several potential phosphorylation sites and shares sequence homology with vesicular coat proteins that are phosphorylated (Keen and Black, 1986; Keen et al., 1987; Hurtley, 1993) , we examined whether (3-NAP is phosphorylated. When mouse brain extracts were immunoprecipitated with Nb antiserum and immunoprecipitates were incubated with [~,-32P]ATP, a phosphorylated band that comigrated exactty with (3-NAP was detected ( Figure 4B ). Similarly, when brain extracts were incubated with [~,-32P]ATP prior to immunoprecipitation, the same band was detected (data not shown). Phosphoamino acid analysis revealed that (3-NAP was phosphorylated on serine and threonine in approximately a 5:1 ratio. Since no exogenous kinases were added to these extracts, these data demonstrate that (3-NAP either coimmunoprecipitates with and is phosphorylated by a protein kinase or is autophosphorylated. To examine whether (3-NAP is phosphorylated in vivo, we metabolically labeled a smallcell lung cancer cell line expressing (3-NAP (Darnell et al., 1991) with inorganic 3~p and immunoprecipitated (3-NAP.
Immunoprecipitates with anti-Nb, but not with an irrelevant serum, contained phosphorylated (3-NAP ( Figure 4B ), demonstrating that (3-NAP is phosphorylated in vivo.
Cellular Distribution of (3-NAP
Adaptin and COP proteins cycle between unassembled cytoplasmic pools and assembled membrane-associated complexes, where they mediate vesicle transport functions (Robinson, 1994; Rothman, 1994) . To determine the cellular distribution of (3-NAP, we examined mouse brain cytoplasmic and membrane fractions. Western blot analysis revealed that (3-NAP is present in roughly equal proportions in mouse brain cytoplasm (40o) and membrane (60°) ( Figure 4C) . A significant component of this cytoplasmic pool is present in the neuronal cell soma, as evidenced by confocal laser microscopy (see Figure 2D ). Thus (3-NAP, like the adaptin and COP proteins, may cycle between a cytoplasmic pool and a membrane-bound fraction.
To investigate whether (3-NAP phosphorylation is related to its subcellular distribution, extracts were incubated with [7-32P]ATP, separated into cytoplasmic and membrane fractions, and immunoprecipitated with Nb antiserum. (3-NAP was efficiently phosphorylated in both cytoplasmic and membrane fractions ( Figure 4D ). When (3-NAP was immunoprecipitated from each fraction prior to incubation with [7-32P]ATP, both immunoprecipitates contained phosphorylated (3-NAP (data not shown). These results demonstrate that both cytoplasmic and membrane-bound (3-NAP associate with a protein kinase.
The addition of exogenous calcium to brain extracts simulates depolarization of a neuron and alters the cellular localization of proteins such as synapsin and dynamin within the nerve terminal (Sihra et al., 1989; Liu et al., 1994) . To examine whether the cellular distribution of (3-NAP might relate to neuronal activity, we added calcium to brain extracts prior to cellular fractionation and immunoprecipitation. The presence of 3 mM calcium resulted in a 4-fold decrease in the cytoplasmic fraction of either phosphorylated (3-NAP ( Figure 4D ) or (3-NAP detected by Western blotting ( Figure 4C ). This effect was proportional to the amount of calcium added, since smaller shifts were observed with lower concentrations of calcium (data not shown). We cannot exclude the possibility that the disappearance of (3-NAP from the cytoplasm is due to proteolytic degradation; however, we favor the interpretation that 13-NAP shifts to the membrane in the presence of calcium, since EGTA was used throughout the preparation of these extracts and we do not detect any 13-NAP degradation products in the presence of calcium ( Figure 4D ). These data suggest that I~-NAP shifts its cellular localization during calcium influx in neurons.
Localization of p-NAP in the Nerve Terminus
The neuron-specific localization of (3-NAP led us to investigate whether the (3-NAP protein was present in the nerve terminal. Synaptosomes were prepared from mouse brain homogenates (Dunkley et al., 1986) ; (3-NAP was detected in each of the fractions from the purification, including the synaptosomal fraction ( Figure 5A ). To control for the integrity of the final synaptosomal preparation, we assayed for the presence of synaptic vesicle proteins (synapsin and synaptophysin) and a somatodendritic marker (transferrin receptor) in each fraction (Cameron et al., 1991; Mundigl et al., 1993) . Synapsin and synaptophysin were detected in each fraction in levels comparable with (3-NAP, while the transferrin receptor was undetectable in either the crude synaptosome fraction (P2) or the purified synaptosomal fraction ( Figure 5A ).
To determine the distribution of (3-NAP within the nerve terminal, we assayed for the presence of (3-NAP in highly were isolated from brain homogenates by differential centrifugation. P3 was lysed by osmotic shock and fractionated into a heavy membrane fraction (LP1), a light membrane fraction enriched in nerveterminal vesicles (LP2), and its supernatant (LS2). The CPG fraction contains a population of nerve-terminal vesicles purified from LP2 by CPG chromatography. (C) Crude vesicles from LP2 fractions were resolved with an $1000 gel filtration column. Aliquots (15 i11) of column fractions (as indicated) were directly spotted on nitrocellulose, incubated with the indicated antibodies, and visualized by chemiluminescence. SY38, synaptophysin.
purified vesicle preparations by Western blot analysis. Figure 5B shows the distribution of 13-NAP in fractions obtained during the purification of synaptic vesicles by chromatography on controlled pore glass (CPG) beads (Huttner et al., 1983) ; J3-NAP levels were compared with synapsin I, a synaptic vesicle protein, and syntaxin 1, a t-SNARE found in purified synaptic vesicles (Walch-Solimena et ai., 1995) . p-NAP is present in the supernatants (cytoplasmic pools) of partially purified synaptosomes ( Figure 5B , lane $3) and partially purified synaptic vesicle fractions (lane LS2). The presence of 13-NAP in the $3 and LS2 soluble fractions is similar to that found with other nerve-terminal proteins that distribute between vesicle-bound and soluble pools, including dynamin and p145 (McPherson et al., 1994) . In contrast, synapsin and syntaxin are present only in the membrane fractions and purified vesicles ( Figure 5B ). ~-NAP is also readily detected in the pu re vesicle fraction ( Figure 5B , lane CPG), although it is not enriched. 13-NAP is not enriched in the CPG fraction relative to LS2 and LP2 fractions, suggesting that there is less G-NAP protein per vesicle than synapsin or syntaxin, that the association of ~-NAP with vesicles is labile (see Barlowe et al., 1994) , or that it purifies with a distinct population of nerve-terminal vesicles. For example, dynamin and p145, which cycle between nerve-terminal vesicles and the cytoplasm, and KIF2, which binds to a subset of nerve-terminal vesicles, are deenriched in CPG-purified vesicles to a similar or greater degree than is J3-NAP (McPherson et al., 1994; Noda et al., 1995) .
To investigate whether ~-NAP purifies with a distinct population of nerve-terminal vesicles, we fractionated crude nerve-terminal vesicles (LP2) using an $1000 gel filtration column. Fractions from the column were assayed under nondenaturing conditions for the presence of clathrin, G-NAP, or the synaptic vesicle marker synaptophysin. 13-NAP is enriched in peak fractions (30-32) that elute between those enriched in clathrin (22-26) and synaptophysin (36-38) ( Figure 5C ). The specificity of reactivity with I~-NAP antibody was confirmed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis of column fractions. Furthermore, electron microscopic examination of fractions 20-46 revealed vesicles with morphologically distinct coats in the clathrin-containing fractions (see below) and a progressive decrease in the size of vesicles in the later fractions.
To localize ~-NAP within the nerve terminal and to determine whether ~-NAP was directly associated with neuronal vesicles, we performed imrnunogold electron microscopy of purified synaptosomes. Plastic-embedded sections revealed G-NAP immunoreactivity in presynaptic nerve termini ( Figure 6A ) and in axons (data not shown). Immunoelectron microscopy of fixed cryosections revealed a similar pattern of reactivity, with better preservation of vesicle morphology ( Figure 6B) ; at high magnification, much of the 13-NAP reactivity was evident on or near nerveterminal vesicles.
Clathrin-and ~-NAP-enriched $1000 fractions were examined for immunoreactivity with gold-conjugated 13-NAP antibody by negative-stain electron microscopy. Approximately two thirds of the vesicles in the 13-NAP-enriched fractions showed staining (defined as at least five 10 nm gold particles per vesicle), while essentially no vesicles in the clathrin-enriched fraction were stained (Figures 6C-6F ). An irrelevant gold-conjugated antibody showed no vesicle reactivity (data not shown). We conclude that 13-NAP is present within the nerve terminal as both a cytoplasmic pool and a vesicle membrane-bound fraction.
Discussion

A Neuron-Specific Coat Protein is a Target Antigen in Cerebellar Degeneration
We have shown that antiserum from a patient with immune-mediated cerebellar degeneration (Darnell et al., Sections stained with no primary antibody or a control non reactive primary antibody showed no staining (data not shown), (C-E) Nerve-terminal vesicles separated on an $1000 column were incubated with 10 nm goldconjugated anti-Nb antibody and examined by negative-stain electron microscopy. Approximately 67% (125 of 186) of vesicles from 13-NAP fractions (30-32) stained heavily (more than five gold particles per vesicle) and had an average diameter of 65 nm Nonreactive vesicles in these fractions are also evident (E). Magnification in (C), 79,000 x ; in (D) and (E), 55,000 x. (F) Vesicles from a clathrin-enriched fraction (23) had a morphologically distinct coat and did not stain (magnification, 55,000 x ) 1991) identifies a neuron-specific vesicle coat protein that we have named I3-NAP. The #-NAP cDNA encodes a unique protein with a predicted Mr of 120 kDa that has homology to the vesicle coat proteins 13-adaptin and #-COP. [~-NAP is most closely homologous with the human and Drosophila 13-adaptins (Ponnambalam et al., 1990; Camidge and Pearse, 1994) , followed by #-adaptins of other mammals, yeast, and to a lesser degree I3-COP (Duden et al., 1991) . These homologies are restricted to the N-terminal 577 amino acids of 13-NAP. Since the N-terminus is thought to harbor the major signal for targeting adaptors to the vesicular membrane (Robinson, 1994) , our results suggest that #-NAP binds to vesicle membranes by a mechanism shared by the adaptins and #-COP. The C-terminus of ~-NAP diverges from 13-adaptin and J3-COP, and, as suggested for #-adaptin (Kirchhausen et al., 1989) , this unique region may mediate specific protein interactions. In 13-NAP, the C-terminal region contains an acidic and serine-rich stretch of amino acids that encodes the epitope for the cerebellar degeneration antibody Nb. Thus, if the Nb antibody is directly involved in cerebellar degeneration, a plausible mechanism would be by binding to and interfering with the function of this charged region of 13-NAP. A likely role for this region isto mediate interactions with a positively charged protein domain. This suggestion is supported by the observation that ~-NAP shows a high degree of sequence similarity in this region to an acidic and serine-rich region of YNSRP, a protein which itself binds positively charged proteins (Lee et al., 1991) . These observations suggest that by binding to a protein-interacting domain of #-NAP, the Nb antibody could abrogate protein and ultimately neuronal function, leading to cerebellar degeneration. More generally, since vesicle-associated proteins within the nerve terminal consistently appear as target antigens in AIND, we speculate that antibodies gain access to the nerve terminal by an unknown mechanism and inhibit protein function there.
~-NAP expression is restricted to the mouse nervous system throughout development and in adulthood. The early developmental expression of [3-NAP in postmitotic neurons at E12, prior to the bulk of synaptogenesis (Jacobson, 1991) , together with the localization of #-NAP to the nerve terminus, suggests that ~-NAP is important for both the development and maintenance of mature synapses. The restricted expression of 13-NAP to neurons at all times in development is consistent with the hypothesis that it is immunogenic because it is normally sequestered from the immune system.
A Model for the Role of J~-NAP in Neurons
We have found that #-NAP is part of a multisubunit coat protein complex; I3-NAP coimmunoprecipitates with p47 (F. Simpson, L. S. N., R. B. D., and M. S. Robinson, unpublished data) , a coat protein related to the AP50 adaptor subunit (Pevsner et al., 1994) . #-NAP itself is present in both cytoplasmic and membrane fractions (Figures 2, 4 , and 5), suggesting that the #-NAP coat protein complex cycles between assembled (membrane-associated) and unassembled (cytoplasmic) pools. Within the neuron, 13-NAP localizes to both the cell body ( Figure , . In both the neuronal celt body and the axon terminus, ~-NAP is depicted as a cytoplasmic pool that is recruited to nascent vesicles budding from endosomes. Membrane recruitment may be stimulated by neuronal depolarization and increased intracellular calcium. An undefined signal, perhaps involving GTP hydrolysis (Rothman, 1994) , is predicted to release 13-NAP back to the cytoplasmic pool. This model depicts 13-NAP as an apical sorting coat protein, sorting nascent vesicles from the cell body toward the axon terminus.
axon terminus, where it directly associates with a subset of neuronal vesicles ( Figures 5 and 6 ). Notably, p47 itself was isolated with an antibody made to isolated nerveterminal vesicles (Pevsner et al., 1994) . Taken together, these observations suggest that ~-NAP is a component of a new class of coat proteins that mediate the sorting and transport of vesicle membrane proteins between the neuronal cell body and the nerve terminus.
One model for the function of such a neuron-specific coat protein (Figure 7) is that 15-NAP mediates anterograde sorting and transport of vesicle membrane proteins from the cell body to the axon terminus. Anterograde sorting to the axon terminus is thought to correspond to apical sorting in polarized epithelial cells (Rodriguez-Boulan and Powell, 1992; Ikonen et al., 1993; Mundigl and DeCamilli, 1994) . The localization of 13-NAP to both the cell body and the nerve terminus suggests that it might act as an apical sorting coat protein in neurons. Since apical transport may involve sorting through an endosome (Barroso and Sztul, 1994; Matter and Mellman, 1994) , 13-NAP may coat nascent vesicle membrane proteins budding from endosomes in the cell body prior to their transport to the axon terminus. Subsequent to budding, the 13-NAP coat protein complex might interact with anterograde motor proteins involved in vesicle transport such as KIF1A (Okada et al., 1995) .
In this context, ~-NAP may also play a role within the nerve terminal itself. Electron microscopic studies of stimulated nerve terminals have revealed that vesicles recycle via axonal endosomes (Heuser and Reese, 1973) . While clathrin and AP-2 adaptors appear to mediate the reuptake of nerve-terminal vesicles in the axon terminus, the variable morphology of such vesicles does not correspond to the homogenous size of most nerve-terminal vesicles (Mundigl and DeCamilli, 1994) . These observations suggest that additional coat proteins might mediate vesicle budding from axonal endosomes; the presence of 13-NAP in a membrane-bound and soluble pool in the nerve terminus is consistent with such a role.
Finally, this model raises the possibility that ~-NAP may be a neuron-specific form of a general class of coat proteins involved in vesicle transport to the apical membrane surface of polarized cells. In support of this suggestion there is preliminary evidence of a coat protein with homology to 13-COP that is associated with endosomes in nonneuronal cells (see Matter and Mellman, 1994) . Moreover, p47 has both neuron-specific (p47B) and generally expressed (p47A) forms (Pevsner et al., 1994) , suggesting that a ~-NAP-related protein may exist in nonneuronal cells.
A second model for I~-NAP function is that it mediates retrograde, rather than anterograde, movement of vesicle membrane proteins from the axon terminus toward the cell body. In this model ~-NAP might function in a way similar to 13-adaptin, mediating budding and transport of plasma membrane receptor endocytic vesicles. Some studies have demonstrated nonclathrin-associated coated vesicles within the nerve terminal, which may represent a subpopulation of recycling synaptic vesicles or a separate endocytic pathway (Koenig and Ikeda, 1989; Takei et al., 1995) . A specific role for retrograde vesicle transport from the axon terminal to the cell body in neurons is also suggested by the observation that axonal projections are obliged to transport trophic factor-bound receptors, via receptor-mediated endocytosis, back to the neuronal soma in order to maintain neuronal viability (Curtis and DiStefano, 1994) . Such endocytosed receptors may be targeted to specific compartments within the neuronal cell body, and thus might require specific vesicle coat proteins.
Regulation of I~-NAP Function
The phosphorylation of 13-NAP and its apparent shift to the membrane upon the addition of exogenous calcium suggest ways in which the function of I~-NAP may be regulated. A number of vesicle-associated proteins present in the nerve terminal cycle between the cytoplasm and membrane in a phosphorylation-and calcium-dependent manner (Sihra et al., 1989; Davletov et al., 1993; DeBello et al., 1993; Liu et al., 1994) . Although we have not identified a protein kinase inhibitor that blocks I~-NAP phosphorylation, 13-NAP and p47 coimmunoprecipitate under conditions used in our phosphorylation assays. Since AP50 is thought to harbor protein kinase activity (Keen and Black, 1986; Keen et al., 1987) , our results suggest the possibility that p47 similarly acts as a protein kinase coimmunoprecipitating with and phosphorylating ~-NAP in brain extracts. Alternatively, 13-NAP may coimmunoprecipitate with another kinase involved in regulation of vesicle recycling in neurons. The disappearance of 13-NAP from the cytoplasm of neurons upon addition of exogenous calcium suggests that neuronal depolarization, with its concomitant rise in intracellular calcium, may promote vesicle coating by 13-NAP.
Experimental Procedures
Cloning and Sequencing of NAP cDNA Autoimmune antiserum was used to screen a cerebellar expression library (ATCC) as described previously (Buckanovich et al., 1993) to identify clone ;LNbl. The XNbl 1.4 kb EcoRI insert was subcloned into pBluescript (-) to yield pNB1, which was used to screen human cerebellar and hippocampal and mouse brain cDNA libraries (Stratagene) to obtain the complete human and mouse cDNA sequences. The cDNAs were sequenced on both strands by the dideoxy termination method using a Sequenase kit (United States Biochemical).
Fusion Protein and Affinity Purification of Nb Antiserum
A 450 bp fragment of ;~Nbl was subcloned into pGEX-2T (Pharmacia) to produce a GST-tagged fusion protein, which was purified using glutathione-agarose beads (Pharmacia). Rabbit antiserum was prepared with GST-Nb protein further purified by Mono Q-Sepharose FPLC. Nb antiserum was affinity pu rifled with GST fusion protein covalently coupled to CNBr-Sepharose 4B (Pharmacia).
Immunohistochemistry and Immunofluorescence
ImmunohistochemicaJ analyses were performed on 12 ~m frozen sections of mouse brain fixed for 2 min in 1:1 acetone:methanol as previously described (Buckanovich et al., 1993) . Confocal images were collected using a Bio-Rad confocal microscope.
Northern Blot Analysis and In Situ Hybridization
Antisense riboprobe prepared by in vitro transcription from linearized pNB1 with T7 RNA polymerase (specific activity of 109 cpm/l~g) was used for Northen blot analysis as described previously (Buckanovich et al., 1993) . In situ hybridization was performed essentially as described (Gibbs and Pfaff, 1994) using 33p-labeled sense and antisense riboprobes transcribed from a mouse 15-NAP cDNA containing the 5'-most 1.9 kb of the cDNA.
Western Blot, Immunoprecipitation, and Phosphorylation r-NAP was detected from mouse brain extracts prepared in NET buffer (0.1% NP-40, 0.15 M NaCI, 50 mM Tris-HCl[pH 7.4]) with protease inhibitors (100 #g/ml aprotinin, 0.5 mM PMSF, 10 #g/ml leupeptin). Proteins were electrophoresed on 10% SDS-polyacrylamide gels and detected with either 12Sl-labeled protein A as described previously (Darnell et al, 1991) or a nonradioactive detection system (ECL; Amersham).
For subcellular fractionations, mouse brains were lysed in hypotonic buffer (10 mM HEPES [pH 8.0], 1.5 mM MgCI2, 10 mM KCI, 1 mM DTT with protease inhibitors), and supernatant from a 15,000 x g centrifugation was separated into cytoplasmic and membrane fractions by centrifugation at 100,000 x g for 40 min.
For phosphorylation assays, mouse brains were lysed in NET or BIPA (0.15 M NaCI, 1% Triton X-100, 0.5% Dec, 0.1% SDS, 0.05 M Tris-HCI [pH 7.5]) buffer with protease inhibitors and 0.1 mM NaV04; PKC buffer (20 mM Tris-HCI [pH 7.4], 10 mM MgOAc, 1 mM EGTA, 2 mM DTT) and 100 mM ATP containing 100 #Ci of [y-32P]ATP (3000 Ci/mmole; Amersham) were added, and reactions were incubated at 30°C for 5 min. Immunoprecipitates were washed and analyzed by SDS-PAGE and autoradiography. For in vivo phosphorylation assays, a small-cell lung cancer cell line, H209 (ATCC), was grown for 2 hr in phosphate-free RPMI medium and labeled with inorganic phosphate (32p, 1 mCi/ml; Amersham) for 3 hr, lysed in RIPA buffer, immunoprecipitated with Nb antiserum, and analyzed by autoradiography. Phosphoamino acid analysis was performed as described elsewhere (Nairn and Greengard, 1987) .
Synaptosome Analysis
Synaptosomes were prepared from adult mouse brains using Percoll gradients as previously described (Dunkley et al, 1986) . The protein concentration of each fraction was determined using the BCA reagent (Pierce), and equal amounts of total protein were analyzed by Western blot with polyclonal synapsin antibody (a gift from A. Nairn) and monoclonal transferrin receptor (Amersham) and synaptophysin (SY38; Accurate Chemical and Scientific Corporation) antibodies. The synaptic vesicle blot was a gift from P. De Camilli.
Isolation of Nerve-Terminal Vesicles
Crude nerve-terminal vesicles (LP2 fractions) from 60 mouse brains were resuspended in buffer 88 (20 mM K-HEPES, 0.25 M sorbitol, 0.15 M KOAc, 1 mM MgOAc [pH 6.8] ) and centrifuged at 14,000 x g for 5 rain, and the supernatants were loaded onto a 77 ml Sephacryl $1000 column (40 cm x 1.6 cm) equilibrated with buffer 88. Column fractions (2.0 ml) were analyzed by directly spotting 15 p.I onto prewet nitrocellulose filters using a 96-well dot blot apparatus (Schleicher & Schuell); filters were blocked with 5°/o milk in PBS, incubated with primary antibodies, and detected with ECL.
Electron Microscopy
Synaptosomes were fixed in 4.0% paraformaldehyde, 0.5% glutaraldehyde for 30 min, dehydrated, and embedded in L. R. White resin (Electron Microscopy Science). Pale gold sections were collected on nickel grids, incubated with affinity-purified rabbit Nb antiserum at 1: 100 dilution, and probed with goat anti-rabbit antiserum conjugated to 10 nm gold (Amersham). For cryoultramicrotomy, P2 fractions fixed as described above were infused with 2.3 M sucrose, processed as described previously (Tokuyasu, 1986) , and probed with 10 nm goldlabeled rabbit antiserum. For analysis of $1000 column fractions, vesicles were concentrated by centrifugation at 134,000 x g for 2 hr and resuspended in one twentieth volume of buffer 88, followed by addition of gold-conjugated Nb antibody. Samples were incubated overnight at 4°C, applied directly to nickel grids, and negative stained with 2% ammonium molybdate (pH 7.0).
